Landos Biopharma Inc.
13F holders, Q1 2024 (March 31)1holders
$22.25avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Landos Biopharma Inc. in their 13F filings. The largest holder was Cornerstone Planning Group LLC ($267).
- Company
- Landos Biopharma Inc.
- CUSIP
- 515069102
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Cornerstone Planning Group LLC | 0.00% | No change | 12 | $267 |
"% of holder's portfolio" is LANDOS BIOPHARMA INC's weight in each manager's 13F, not the share of Landos Biopharma Inc. the manager owns.